HomeIGMS • NASDAQ
add
IGM Biosciences Inc
Previous close
$1.27
Day range
$1.27 - $1.28
Year range
$0.92 - $22.50
Market cap
76.57M USD
Avg Volume
1.06M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Revenue | 143.62M | 11,353.19% |
Operating expense | 15.44M | 45.03% |
Net income | 97.58M | 303.72% |
Net profit margin | 67.94 | 101.78% |
Earnings per share | 1.58 | 300.00% |
EBITDA | 128.62M | 362.06% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 104.31M | -59.32% |
Total assets | 106.99M | -68.21% |
Total liabilities | 6.06M | -97.17% |
Total equity | 100.93M | — |
Shares outstanding | 60.29M | — |
Price to book | 0.76 | — |
Return on assets | 204.19% | — |
Return on capital | 440.21% | — |
Cash Flow
Net change in cash
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Net income | 97.58M | 303.72% |
Cash from operations | -50.79M | -35.89% |
Cash from investing | 44.54M | 81.63% |
Cash from financing | 12.00K | -98.05% |
Net change in cash | -6.24M | 49.04% |
Free cash flow | 71.68M | 413.77% |
About
Founded
1993
Website
Employees
16